Write in a clean editor, then format for Global & Regional Health Technology Assessment in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Global & Regional Health Technology Assessment is a peer-reviewed journal published by SAGE, covering Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Economic and Financial Impacts of Cancer.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Global & Regional Health Technology Assessment, 12(3), pp. 45–58.
Formats any DOI in Global & Regional Health Technology Assessment style. No sign-up. |
| Publishes research in | Health Systems, Economic Evaluations, Quality of Life Pharmaceutical Economics and Policy Economic and Financial Impacts of Cancer Biosimilars and Bioanalytical Methods Pharmaceutical studies and practices |
| ISSN | 2283-5733 |
| Citation impact (2-yr) | 0.84 |
| h-index | 10 |
| i10-index | 13 |
| Total citations | 716 |
| Article processing charge | $1,617 |
| Open access | Yes |
| Top institutions publishing here | University of Rome Tor Vergata |
| Journal website | journals.aboutscience.eu |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Chronic pain negatively impacts on sick people's daily life and their working ability, and it is a heavy financial burden on the health systems. This article is aimed at evaluating the social costs of chronic pain in Italy. The analysis is based on national tariffs and prices and on epidemiologic, health resource consumption, and absence…
Traditionally, the majority of health economic modelling has been performed in spreadsheet calculators such as Microsoft Excel as it is perceived to be more transparent and easy to use. However, as the modelling requirements become more realistic and therefore complex, spreadsheets become increasingly cumbersome and difficult to manage. We argue that specialist statistical packages such…
Objectives: To evaluate the cost-effectiveness analysis (CEA) of caplacizumab in combination with plasmapheresis (PEX) and immunosuppression compared to PEX and immunosuppression in the treatment of acute episodes of iTTP. Methods: A Markov model was used to conduct the CEA from the perspective of the hospital, over a lifetime horizon. Clinical data derived from HERCULES trial…
Introduction: A timely diagnosis of osteoporosis is key to reducing its growing clinical and economic burden. Radiofrequency Echographic Multi Spectrometry (REMS), a new diagnostic technology using an ultrasound approach, has been recognized by scientific associations as a facilitator of patients' care pathway. We aimed at evaluating the costs of REMS vs. the conventional ionizing technology…
A cost analysis model was developed to evaluate the 3-year cost of treating vision impairment associated with chronic diabetic macular oedema (DMO) with either a single fluocinolone acetonide (FAc) implant or with 14 ranibizumab injections in the National Health Service (NHS) in England. The model accounts for the overall direct cost of treatment in both…
